Tag: research

Generate:Biomedicines
United States

Generate: Biomedicines Expands C-suite with Chief Corporate Affairs Officer and Chief Technical Operations Officer

SOMERVILLE, Mass. – Generate:Biomedicines today announces two key appointments, welcoming Kimberly (Kym) White as the new Chief Corporate Affairs Officer and announcing the promotion of Lisa Wyman to Chief Technical Operations Officer. These appointments not only enhance the company’s leadership team, but also reflect its commitment to gender diversity, with over half of the leadership team represented by women. White’s arrival and Wyman’s promotion are … Continue reading Generate: Biomedicines Expands C-suite with Chief Corporate Affairs Officer and Chief Technical Operations Officer

Impact Newswire
Scenic Biotech
Europe

Scenic Biotech Enters into Research Collaboration with Bristol Myers Squibb

Bristol Myers Squibb gains access to Scenic’s Cell-Seq technology platform to unlock the underlying genetic interactions of cellular pathways for undisclosed targets Scenic to receive an upfront payment and potential additional payments contingent on the achievement of research, development and commercial milestones AMSTERDAM – Scenic Biotech, a pioneer in the field of modifier therapies for severe genetic disorders, today announced that it has entered into … Continue reading Scenic Biotech Enters into Research Collaboration with Bristol Myers Squibb

Impact Newswire
CEL-SCI
United States

CEL-SCI Appoints Mario Gobbo to Its Board of Directors

VIENNA, Va.–(BUSINESS WIRE)–CEL-SCI Corporation (NYSE American: CVM) today announced the appointment of Mario Gobbo to its Board of Directors. “This is an exciting and extremely important moment to join the board of CEL-SCI as it is on the brink of developing a product that will revolutionize certain head and neck cancer therapies and probably other deadly cancers. I am proud and honored to become part of the … Continue reading CEL-SCI Appoints Mario Gobbo to Its Board of Directors

Impact Newswire
KBI Biopharma
United States

KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer

DURHAM, N.C. – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and global cGMP contract development and manufacturing organization (CDMO), today announced the appointment of Jean-Baptiste (JB) Agnus as Chief Business Officer, solidifying KBI’s Executive Team. “Our dedication to growth and commitment to our partners, their patients, and our people guide every decision at KBI Biopharma”Post this JB brings more than two decades of … Continue reading KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer

Impact Newswire